Testing a new injection for safety in healthy adults
Part of Skin clinical trials.
This study tests a new medicine called SPOT-mRNA01, given as a small injection under the skin, to see if it is safe and well-tolerated. It is an early-stage trial in healthy volunteers, which means it is not yet testing whether the medicine works for a disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are generally healthy, with no serious medical conditions.
- You have no skin problems, infections, or recent cosmetic treatments (like laser or chemical peels) near the injection area.
- You are not pregnant or breastfeeding.
- You have no history of severe allergic reactions or drug abuse.
- You have not participated in another clinical trial in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a food supplement can improve skin health in people with normal to dry skin. You would take the supplement or a placebo every day and have your skin checked over a few weeks.
This study tests a new device called MD60000 for treating wrinkles and other skin imperfections caused by aging. It aims to see how well it works and if it is safe for adults up to age 65.
This trial tests a new experimental drug called mRNA-0184, given as an injection under the skin, to see if it is safe and well tolerated in healthy people. It is an early-phase study, so participants will help determine if the drug can move forward to larger trials.
This trial tests a new drug called QLS2312, given as an injection, to see if it is safe and how the body handles it. It is an early study in healthy volunteers that helps decide if the drug can be studied in people with certain conditions.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
This is an early study testing a new medicine called CIT-013. It is given as an injection under the skin, and the goal is to see if it is safe and how the body handles it. It is for healthy volunteers.
Hear when a new Skin Aging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.